Maverick Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.4M | Buy |
4,377,690
+4,347,398
| +14,352% | +$72.9M | 1.1% | 27 |
|
|
2025
Q1 | $466K | Buy |
30,292
+16,137
| +114% | +$248K | 0.01% | 223 |
|
|
2024
Q4 | $312K | Sell |
14,155
-54,624
| -79% | -$1.2M | 0.01% | 182 |
|
|
2024
Q3 | $1.24M | Buy |
68,779
+3,296
| +5% | +$59.4K | 0.02% | 184 |
|
|
2024
Q2 | $1.06M | Buy |
65,483
+7,938
| +14% | +$129K | 0.02% | 210 |
|
|
2024
Q1 | $812K | Sell |
57,545
-5,502
| -9% | -$77.6K | 0.02% | 150 |
|
|
2023
Q4 | $658K | Buy |
63,047
+29,942
| +90% | +$313K | 0.01% | 159 |
|
|
2023
Q3 | $338K | Sell |
33,105
-17,483
| -35% | -$178K | 0.01% | 208 |
|
|
2023
Q2 | $381K | Sell |
50,588
-2,277
| -4% | -$17.1K | 0.01% | 300 |
|
|
2023
Q1 | $468K | Buy |
52,865
+21,416
| +68% | +$190K | 0.01% | 290 |
|
|
2022
Q4 | $287K | Buy |
+31,449
| New | +$287K | 0.01% | 300 |
|
|
2021
Q3 | – | Sell |
-44,879
| Closed | -$444K | – | 789 |
|
|
2021
Q2 | $444K | Sell |
44,879
-110,962
| -71% | -$1.1M | ﹤0.01% | 396 |
|
|
2021
Q1 | $1.8M | Buy |
155,841
+111,167
| +249% | +$1.28M | 0.02% | 160 |
|
|
2020
Q4 | $431K | Sell |
44,674
-80,503
| -64% | -$777K | 0.01% | 386 |
|
|
2020
Q3 | $1.13M | Buy |
+125,177
| New | +$1.13M | 0.02% | 254 |
|
|
2020
Q1 | – | Sell |
-461,715
| Closed | -$4.53M | – | 541 |
|
|
2019
Q4 | $4.53M | Sell |
461,715
-199,500
| -30% | -$1.96M | 0.07% | 150 |
|
|
2019
Q3 | $4.55M | Buy |
+661,215
| New | +$4.55M | 0.07% | 173 |
|
|
2019
Q2 | – | Sell |
-94,530
| Closed | -$1.48M | – | 341 |
|
|
2019
Q1 | $1.48M | Sell |
94,530
-146,690
| -61% | -$2.3M | 0.02% | 255 |
|
|
2018
Q4 | $3.72M | Buy |
+241,220
| New | +$3.72M | 0.05% | 212 |
|